Approach to the patient with persistent hyperprolactinemia and negative sellar imaging

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages 2211-2216

  Glezer, Andrea ^a   Bronstein, Marcello D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE; PROLACTIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; FEMALE INFERTILITY; HUMAN; HYPERPROLACTINEMIA; MENARCHE; MENSTRUAL CYCLE; PATIENT REFERRAL; PERSISTENT HYPERPROLACTINEMIA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCREENING;

ADULT; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; INFERTILITY, FEMALE; MAGNETIC RESONANCE IMAGING; PROLACTIN; RECURRENCE; SELLA TURCICA;

EID: 84863595758     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2976     Document Type: Article

References (48)

1. Bronstein MD 2010 Disorders of prolactin secretion and prolactinomas. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 6th ed. Philadelphia: Saunders/Elsevier; 333-357
2. Molitch ME 2008 Drugs and prolactin. Pituitary 11:209-218
3. McKenna TM, Woolf PD 1985 Prolactin metabolic clearance and resistance to dopaminergic suppression in acute uremia. Endocrinology 116:2003-2007
4. Lim VS, Kathpalia SC, Frohman LA 1979 Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation. J Clin Endocrinol Metab 48:101-107 (Pubitemid 9101617)
5. Hou SH, Grossman S, Molitch ME 1985 Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis. Am J Kidney Dis 6:245-249 (Pubitemid 16257626)
6. Yavuz D, Topçu G, Ozener C, Akalin S, Sirikçi O 2005 Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy. Clin Endocrinol (Oxf) 63:520-524 (Pubitemid 41626746)
7. Nardoni A, Marchetti E, Geatti O, Di Piazza V, Rossi G, Cedaro P 1985 Prolactin in chronic alcoholic liver diseases with and without gynecomastia. Minerva Med 76:37-42 (Pubitemid 15146739)
8. Morgan MY, Jakobovits AW, Gore MB, Wills MR, Sherlock S 1978 Serum prolactin in liver disease and its relationship to gynaecomastia. Gut 19:170-174 (Pubitemid 8318426)
9. Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH 1973 Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest 52:2324-2329
10. Hekimsoy Z, Kafesçiler S, Güçlü F, Ozmen B 2010 The prevalence of hyperprolactinemia in overt and subclinical hypothyroidism. Endocr J 57:1011-1015
11. Raber W, Gessl A, Nowotny P, Vierhapper H 2003 Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol (Oxf) 58:185-191 (Pubitemid 36194273)
12. Falaschi P, del Pozo E, Rocco A, Toscano V, Petrangeli E, Pompei P, Frajese G 1980 Prolactin release in polycystic ovary. Obstet Gynecol 55:579-582 (Pubitemid 10068255)
13. Filho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA 2007 Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol 23:267-272 (Pubitemid 46897698)
14. Robin G, Catteau-Jonard S, Young J, Dewailly D 2011 Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality? Gynecol Obstet Fertil 39:141-145
15. Faubion WA, Nader S 1997 Spinal cord surgery and galactorrhea: a case report. Am J Obstet Gynecol 177:465-466 (Pubitemid 27385734)
16. Marino A, Patel T, Whitten E, Peiris AN 2009 Persistent hyperprolactinemia following mammoplasty: a rare association. Tenn Med 102:47-48
17. Modest GA, Fangman JJ 2002 Nipple piercing and hyperprolactinemia. N Engl J Med 347:1626-1627
18. Hammond KR, Steinkampf MP, Boots LR, Blackwell RE 1996 The effect of routine breast examination on serum prolactin levels. Fertil Steril 65:869-870 (Pubitemid 26096934)
19. Saraç F, Tütüncüoolu P, Ozgen AG, Saygili F, Yilmaz C, Bilgen I, Memip A 2008 Prolactin levels and examination with breast ultrasound or mammography. Adv Ther 25:59-66
20. Glezer A, Soares CR, Vieira JG, Giannella-Neto D, Ribela MT, Goffin V, Bronstein MD 2006 Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. J Clin Endocrinol Metab 91:1048-1055 (Pubitemid 43357779)
21. Gibney J, Smith TP, McKenna TJ 2005 Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 62:633-643 (Pubitemid 40825930)
22. Cortet-Rudelli C, Sapin R, Bonneville JF, Brue T 2007 Etiological diagnosis of hyperprolactinemia. Ann Endocrinol (Paris) 68:98-105
23. Gibney J, Smith TP, McKenna TJ 2005 The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 90:3927-3932 (Pubitemid 41058153)
24. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ 2002 Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87:5410-5415 (Pubitemid 36034335)
25. Hattori N, Ishihara T, Saiki Y, Shimatsu A 2010 Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. Clin Endocrinol (Oxf) 73:792-797
26. Kavanagh-Wright L, Smith TP, Gibney J, McKenna TJ 2009 Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clin Endocrinol (Oxf) 70:599-605
27. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, Martin PM, Jaquet P, Brue T 2002 Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 87:581-588 (Pubitemid 34158222)
28. Khandwala HM 2006 Macroprolactinemia in a patient with infertility and hyperprolactinemia. South Med J 99:1282-1284 (Pubitemid 44875855)
29. Mancini T, Casanueva FF, Giustina A 2008 Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 37:67-99, viii (Pubitemid 351146629)
30. De Bellis A, Colao A, Pivonello R, Savoia A, Battaglia M, Ruocco G, Tirelli G, Lombardi G, Bellastella A, Bizzarro A 2007 Antipituitary antibodies in idiopathic hyperprolactinemic patients. Ann NY Acad Sci 1107:129-135 (Pubitemid 47528789)
31. Glezer A, D'Alva CB, Salgado LR, Musolino NR, Serafini P, Vieira JG, Bronstein MD 2002 Pitfalls in pituitary diagnosis: peculiarities of three cases. Clin Endocrinol (Oxf) 57:135-139 (Pubitemid 34785895)
32. Hauache OM, Rocha AJ, Maia Jr AC, Maciel RM, Vieira JG 2002 Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol (Oxf) 57:327-331 (Pubitemid 35013811)
33. Mounier C, Trouillas J, Claustrat B, Duthel R, Estour B 2003 Macroprolactinaemia associated with prolactin adenoma. Hum Reprod 18:853-857 (Pubitemid 36426970)
34. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA; The Endocrine Society 2011 Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273-288
35. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A 2006 Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265-273 (Pubitemid 44079693)
36. Muneyyirci-Delale O, Goldstein D, Reyes FI 1989 Diagnosis of stress-related hyperprolactinemia. Evaluation of hyperprolactinemia with rest test. N Y State J Med 89:205-208
37. Vieira JG, Oliveira JH, Tachibana T, Maciel RM, Hauache OM 2006 Avaliação dos níveis de prolactina sérica: énecessário repouso antes da coleta? Arq Bras Endocrinol Metabol 50:569-570 [Article in Portuguese] (Pubitemid 44298536)
38. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF 1994 A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 331:904-909 (Pubitemid 24299871)
39. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E 2007 Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356:29-38 (Pubitemid 46041751)
40. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G 2007 Valve heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 356:39-46 (Pubitemid 46041752)
41. Colao A, Savastano S 2011 Medical treatment of prolactinomas. Nat Rev Endocrinol 7:267-278
42. Dekkers OM, Lagro J, Burman P, Jørgensen JO, Romijn JA, Pereira AM 2010 Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 95:43-51
43. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A 1989 The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68:412-418 (Pubitemid 19052886)
44. Fernandez I, Touraine P, Goffin V 2010 Prolactin and human tumourogenesis. J Neuroendocrinol 22:771-777
45. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE 2004 Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64:6814-6819 (Pubitemid 39297946)
46. Berinder K, Akre O, Granath F, Hulting AL 2011 Cancer risk in hyperprolactinemia patients: a population-based cohort study. Eur J Endocrinol 165:209-215
47. Anaforoglu I, Ertorer ME, Kozanoglu I, Unal B, Haydardedeoglu FE, Bakiner O, Bozkirli E, Tutuncu NB, Demirag NG 2010 Macroprolactinemia, like hyperprolactinemia, may promote platelet activation. Endocrine 37:294-300
48. Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, Kastelein JJ, Hamann J, Goffin V, von der Thüsen JH, Twickler MT, Aten J 2011 The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol 208: 107-117